These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10236978)

  • 1. The Food and Drug Administration drug registration and listing system.
    Slavin M
    Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA-USP drug product problem reporting program--an update.
    Wheatley LS
    Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797
    [No Abstract]   [Full Text] [Related]  

  • 3. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug information resources for health professionals and consumers.
    Durkin C
    Natl Netw; 1998 Feb; 22(3):10-1. PubMed ID: 10176590
    [No Abstract]   [Full Text] [Related]  

  • 5. How to ask drug companies for help.
    Hayes JD
    Am J Nurs; 1993 Jan; 93(1):38-41. PubMed ID: 8447345
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding the FDA's guarded system for classifying new drugs.
    Schneiweiss F
    Hosp Pharm; 1979 May; 14(5):262-4, 266, 268 passim. PubMed ID: 10316828
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigational drug information is available to the pharmacist.
    Moore RC
    Am J Hosp Pharm; 1979 Nov; 36(11):1480, 1484. PubMed ID: 517531
    [No Abstract]   [Full Text] [Related]  

  • 8. The patient information and education initiative.
    Rheinstein PH; McGinnis TJ; Nightingale SL
    Am Fam Physician; 1995 Dec; 52(8):2377-8, 2381-2. PubMed ID: 7484726
    [No Abstract]   [Full Text] [Related]  

  • 9. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
    Basile EM; Gross M
    Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

  • 11. The medicolegal significance of the package insert.
    Hirsh HL
    Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse reaction reporting program.
    Knobloch CP
    J Am Vet Med Assoc; 1980 Jan; 176(1):29. PubMed ID: 6892526
    [No Abstract]   [Full Text] [Related]  

  • 13. Educating physicians in the use of pharmaceuticals.
    Kaplan NM
    Circulation; 1985 Aug; 72(2 Pt 2):I31-5. PubMed ID: 4006155
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: limitations of the physicians' desk reference 2007.
    Mindel JS; Teich SA; Teich CM; Beam P
    Surv Ophthalmol; 2008; 53(1):82-4. PubMed ID: 18191659
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorrect or unsubstantiated indications listed for selected antimicrobials in the Physicians' Desk Reference.
    Rybak MJ; Gleckman R
    Am J Hosp Pharm; 1979 Jun; 36(6):738. PubMed ID: 463882
    [No Abstract]   [Full Text] [Related]  

  • 16. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN
    J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspectives. New twist on guideline dissemination stirs professional debate, gets slap from FDA.
    Newman L
    Med Health; 1999 Feb; 53(8):suppl 1-4. PubMed ID: 10345551
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points.
    Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rule could mean higher risks for some children.
    Maloney DM
    Hum Res Rep; 1999 Feb; 14(2):3. PubMed ID: 11657603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.